The sympathetic nervous system induces a metastatic switch in primary breast cancer.
Metastasis to distant tissues is the chief driver of breast cancer-related mortality, but little is known about the systemic physiologic dynamics that regulate this process. To investigate the role of neuroendocrine activation in cancer progression, we used in vivo bioluminescence imaging to track the development of metastasis in an orthotopic mouse model of breast cancer. Stress-induced neuroendocrine activation had a negligible effect on growth of the primary tumor but induced a 30-fold increase in metastasis to distant tissues including the lymph nodes and lung. These effects were mediated by β-adrenergic signaling, which increased the infiltration of CD11b(+)F4/80(+) macrophages into primary tumor parenchyma and thereby induced a prometastatic gene expression signature accompanied by indications of M2 macrophage differentiation. Pharmacologic activation of β-adrenergic signaling induced similar effects, and treatment of stressed animals with the β-antagonist propranolol reversed the stress-induced macrophage infiltration and inhibited tumor spread to distant tissues. The effects of stress on distant metastasis were also inhibited by in vivo macrophage suppression using the CSF-1 receptor kinase inhibitor GW2580. These findings identify activation of the sympathetic nervous system as a novel neural regulator of breast cancer metastasis and suggest new strategies for antimetastatic therapies that target the β-adrenergic induction of prometastatic gene expression in primary breast cancers.
Sloan
Erica K
EK
UCLA Norman Cousins Center, Semel Institute for Neuroscience and Human Behavior, Medical Plaza 300, Room 3129, Los Angeles, CA 90095, USA. esloan@ucla.edu
Priceman
Saul J
SJ
Cox
Benjamin F
BF
Yu
Stephanie
S
Pimentel
Matthew A
MA
Tangkanangnukul
Veera
V
Arevalo
Jesusa M G
JM
Morizono
Kouki
K
Karanikolas
Breanne D W
BD
Wu
Lily
L
Sood
Anil K
AK
Cole
Steven W
SW
D000230:Adenocarcinoma / Q000276:immunology / Q000473:pathology*; D000818:Animals; D045744:Cell Line, Tumor; D005260:Female; D008264:Macrophages / Q000276:immunology; D008325:Mammary Neoplasms, Experimental / Q000276:immunology / Q000473:pathology*; D051379:Mice; D008807:Mice, Inbred BALB C; D008819:Mice, Nude; D009362:Neoplasm Metastasis; D013312:Stress, Physiological / Q000276:immunology / Q000502:physiology*; D013564:Sympathetic Nervous System / Q000473:pathology*; D013601:T-Lymphocytes / Q000276:immunology
Proc Natl Acad Sci U S A. 2010 Mar 23;107(12):5681-6
20176930
J Invest Dermatol. 1999 May;112(5):802-9
10233775
BMJ. 2002 Jun 15;324(7351):1420
12065263
Curr Neurovasc Res. 2008 Feb;5(1):1-12
18289016
J Biol Chem. 2007 Oct 12;282(41):29919-26
17716980
Annu Rev Neurosci. 1992;15:87-114
1575451
Rev Epidemiol Sante Publique. 2004 Feb;52(1):53-65
15107693
Int J Oncol. 2002 Jul;21(1):153-7
12063562
J Clin Oncol. 2009 Jul 20;27(21):3418-9
19470918
J Neuroimmunol. 1999 May 3;96(2):182-9
10337916
World J Surg. 2004 Mar;28(3):327-30
14961184
Cancer Causes Control. 2004 Aug;15(6):535-41
15280632
Int J Cancer. 2004 Nov 1;112(2):231-8
15352035
Brain Behav Immun. 2005 Mar;19(2):114-26
15664784
Cancer Res. 2005 Oct 15;65(20):9426-35
16230406
Clin Cancer Res. 2008 Nov 1;14(21):6839-46
18980978
J Clin Oncol. 2006 Mar 1;24(7):1105-11
16505430
Nat Clin Pract Oncol. 2008 Aug;5(8):466-75
18493231
Nat Rev Cancer. 2006 Mar;6(3):240-8
16498446
Am J Public Health. 2000 Oct;90(10):1601-7
11029995
J Neurosci. 2007 Aug 15;27(33):8857-65
17699667
Pharmacol Rev. 2001 Mar;53(1):1-24
11171937
Cancer Cell. 2009 Aug 4;16(2):91-102
19647220
BMJ. 1992 Apr 25;304(6834):1078-81
1586819
Cancer. 2003 Sep 15;98(6):1299-308
12973855
Brain Res Bull. 1998;45(2):183-7
9443838
Am J Epidemiol. 2003 Mar 1;157(5):415-23
12615606
Cancer Cell. 2009 Aug 4;16(2):81-2
19647215
Cancer. 2003 Oct 1;98(7):1504-13
14508839
Nat Med. 2005 Mar;11(3):346-52
15711560
Cancer. 2002 Nov 15;95(10):2237-42
12412179
J Neuroimmunol. 1993 Nov-Dec;48(2):151-60
8227313
J Neuroimmunol. 1994 Sep;53(2):173-80
8071431
Arch Intern Med. 2000 Feb 14;160(3):349-53
10668837
J Immunol. 1998 Apr 1;160(7):3251-8
9531281
Breast Cancer Res. 2006;8(2):R20
16608535
J Immunol. 1998 Jul 15;161(2):610-6
9670934
Am J Physiol. 1999 May;276(5):R1461-8
10233040
Clin Cancer Res. 2003 Oct 1;9(12):4514-21
14555525
Nat Med. 2006 Aug;12(8):939-44
16862152
J Psychosom Res. 1992 Sep;36(6):531-41
1640391
Brain Behav Immun. 1994 Mar;8(1):14-23
8003768
J Interferon Cytokine Res. 2005 Jul;25(7):384-94
16022583
Int J Cancer. 1994 Aug 15;58(4):512-6
8056447
J Virol. 2006 May;80(9):4326-35
16611891
Annu Rev Pharmacol Toxicol. 1995;35:417-48
7598501
Nat Rev Cancer. 2004 Jan;4(1):71-8
14708027
Blood. 2010 Feb 18;115(7):1461-71
20008303